Bibliographic Reference
Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science, 194(4260), 23–28. https://doi.org/10.1126/science.959840
Core Argument
Most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic instability within the original clone that allows sequential selection of increasingly aggressive variant sublines. The biological characteristics of tumor progression (loss of differentiation, invasion, metastasis, therapy resistance) parallel the stages of this genetic evolution.
Methods
This is a perspective/review article synthesizing evidence from three approaches: (i) cytogenetic studies of tumor karyotypes, (ii) glucose-6-phosphate dehydrogenase isoenzyme studies in heterozygous women demonstrating clonality, and (iii) immunoglobulin homogeneity in plasma cell tumors. Nowell draws on chromosomal studies of human leukemias (CGL, acute leukemias), experimental rat sarcomas (Mitelman’s Rous sarcoma work), and solid tumors.
Key Findings
- Most tumors originate from a single cell (unicellular origin), as shown by shared karyotypic abnormalities, G6PD isoenzyme patterns, and immunoglobulin homogeneity.
- Neoplastic cells show higher frequency of mitotic errors and genetic changes compared to normal cells — acquired genetic instability is a defining property of tumor cells.
- Tumor progression follows a stepwise evolutionary sequence: a new variant subpopulation with a selective advantage emerges, outcompetes the previous population, and dominates until an even more favorable variant appears.
- Advanced human malignancies are typically highly aneuploid with individually unique karyotypes, making them “individual therapeutic problems.”
- Chemotherapy and radiation may accelerate tumor evolution both by direct mutagenic action and by immunosuppressive effects that reduce immune-mediated elimination of variants.
- Each patient’s cancer may require individual specific therapy, and even this may be thwarted by emergence of genetically variant sublines resistant to treatment.
Concepts Introduced or Used
clonal-evolution, tumor-progression, selective-sweep, clonal-expansion, genetic-instability, karyotype-evolution, aneuploidy, driver-mutation (implicitly via “selective advantage”), passenger-mutation (implicitly via “metabolic disadvantage”), unicellular-origin, chemotherapy-resistance, immune-evasion, metastasis, oncogene (implicitly via gene loci controlling malignancy)
Entities Referenced
- Philadelphia (Ph) chromosome (BCR-ABL)
- Glucose-6-phosphate dehydrogenase (G6PD)
- Chronic granulocytic leukemia (CGL)
- SV40 virus and chromosome 7 integration
- Xeroderma pigmentosum (DNA repair defect)
- Bloom’s syndrome, Fanconi’s anemia, ataxia telangiectasia (chromosome breakage syndromes)
- Rous sarcoma virus (Mitelman’s rat sarcoma model)
Limitations
As a 1976 perspective article, limitations are not formally discussed. However, Nowell explicitly acknowledges: (i) the model does not fit all tumor types (some exceptions, especially viral tumors, are noted); (ii) the genetic-vs-epigenetic debate is unresolved; (iii) correlations between specific karyotypic changes and tumor progression remain few; (iv) cytogenetics is a “relatively crude means of exploring genetic phenomena” — the genome mapping needed for precise correlations was still incomplete.
Relevance to Clonal Evolution
This is the foundational paper that established the evolutionary theory of cancer. It introduced the concept that tumors evolve through stepwise somatic mutation and subclonal selection, directly paralleling Darwinian natural selection. Every subsequent paper on clonal evolution in cancer (Greaves & Maley 2012, McGranahan & Swanton 2017, Gerstung 2020, Turajlic 2019) explicitly references this paper as the origin of the field.